Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children

Coronavirus disease 2019 (COVID-19) rapidly emerged as a global pandemic, placing imminent stress and burden on healthcare resources and workers worldwide. Many patients who present with a severe COVID-19 infection are at high risk of developing severe acute respiratory distress syndrome (ARDS), lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Edinoff, Amber N., Alpaugh, Edward Sanders, Newgaard, Olivia, Wajid, Irza, Klapper, Rachel J., Cornett, Elyse M., Kaye, Adam M., Iyer, Praneet, Kaye, Alan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142952/
https://www.ncbi.nlm.nih.gov/pubmed/37109418
http://dx.doi.org/10.3390/life13040889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142952/
https://www.ncbi.nlm.nih.gov/pubmed/37109418
http://dx.doi.org/10.3390/life13040889

Ejemplares similares